Effect of Antisecretory Therapy on Atypical Symptoms in Gastroesophageal Reflux Disease

Author: Dore Maria   Pedroni Antonietta   Pes Gianni   Maragkoudakis Emanouil   Tadeu Vincenza   Pirina Pietro   Realdi Giuseppe   Delitala Giuseppe   Malaty Hoda  

Publisher: Springer Publishing Company

ISSN: 0163-2116

Source: Digestive Diseases and Sciences, Vol.52, Iss.2, 2007-02, pp. : 463-468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The effect of proton pump inhibitor (PPI) therapy on extraesophageal or atypical manifestations of gastroesophageal reflux disease (GERD) remains unclear. This study aimed to evaluate the prevalence of atypical manifestations in patients with acid reflux disease and the effect of PPI treatment. Patients with symptoms and signs suggestive of reflux were enrolled. Erosive esophagitis was stratified using the Los Angeles classification. Demographic data and symptoms were assessed using a questionnaire and included typical symptoms (heartburn, regurgitation, dysphagia, odynophagia), and atypical symptoms (e.g., chest pain, sialorrhea, hoarseness, globus sensation, chronic coughing, episodic bronchospasm, hiccup, eructations, laryngitis, and pharyngitis). Symptoms were reassessed after a 3-month course of b.i.d. PPI therapy. A total of 266 patients with a first diagnosis of GERD (erosive, 166; nonerosive, 100) were entered in the study. Presentation with atypical symptoms was approximately equal in those with erosive GERD and with nonerosive GERD, 72% vs 79% (P = 0.18). None of the study variables showed a significant association with the body mass index. PPI therapy resulted in complete symptom resolution in 69% (162/237) of the participants, 12% (28) had improved symptoms, and 20% (47) had minimal or no improvement. We conclude that atypical symptoms are frequent in patients with GERD. A trial of PPI therapy should be considered prior to referring these patients to specialists.